PT  - JOURNAL ARTICLE
AU  - Selena R. Pasadyn
AU  - Daniel Knabel
AU  - Anthony P. Fernandez
AU  - Christine B. Warren
TI  - Cutaneous adverse effects of biologic medications
AID  - 10.3949/ccjm.87a.19119
DP  - 2020 May 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 288--299
VI  - 87
IP  - 5
4099  - http://www.ccjm.org/content/87/5/288.short
4100  - http://www.ccjm.org/content/87/5/288.full
SO  - Cleve Clin J Med2020 May 01; 87
AB  - Biologic therapies have become widely used but often cause cutaneous adverse effects. The authors discuss the cutaneous adverse effects of tumor necrosis factor (TNF) alpha inhibitors, epidermal growth factor receptor (EGFR) inhibitors, small-molecule tyrosine kinase inhibitors (TKIs), and cell surface-targeted monoclonal antibodies, including how to manage these reactions and when to refer to a dermatologist.